NEW YORK (GenomeWeb News) – Agilent Technologies said today that it has entered into a co-marketing agreement with MRM Proteomics that will enable the firms to offer more complete hardware, software, and proteomics kit solutions.

Vancouver-based MRM provides protein quantitation, biomarker, and proteomic services to pharmaceutical, biotech, and diagnostics customers. The company specializes in providing highly multiplexed quantitation of proteins in biosamples from blood, cerebrospinal fluid, and urine, using isotopically labeled internal standards.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.